Literature DB >> 2206969

Skin exudate levels of interleukin 6, interleukin 1 and other cytokines in mycosis fungoides.

F Lawlor1, N P Smith, R D Camp, K B Bacon, A K Black, M W Greaves, A J Gearing.   

Abstract

The role of locally released cytokines in inducing lymphocyte activation and infiltration in the skin lesions of mycosis fungoides has been investigated. The levels of selected cytokines were measured in chamber fluid samples from lesional and control skin. Biologically active interleukin 6 was significantly elevated in lesional samples and a recombinant form of this cytokine was shown to induce lymphocyte migration in an in vitro assay. Biologically active interleukin 1 was detected in all control chamber fluid samples. Significantly reduced levels of this cytokine were present in lesional samples, which may be the result of the release of preformed material. Interleukin 2 and tumour necrosis factor activity, and gamma interferon and granulocyte macrophage colony-stimulating factor immunoreactivity, were not detectable in any of the samples. Interleukins 1 and 6 may play a role in the pathogenesis of the lesional lymphocyte infiltrates in mycosis fungoides.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2206969     DOI: 10.1111/j.1365-2133.1990.tb06288.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

1.  Scleromyxedematous Changes in a Patient With Long-Standing Mycosis Fungoides Who Progressed to Sézary Syndrome.

Authors:  Allen P Miraflor; Melissa P Pulitzer; Patricia L Myskowski; Shamir Geller
Journal:  Am J Dermatopathol       Date:  2019-11       Impact factor: 1.533

2.  Evaluation of cardiovascular disease risk factors in patients with mycosis fungoides.

Authors:  Fatma Pelin Cengiz; Nazan Emiroglu
Journal:  An Bras Dermatol       Date:  2015 Jan-Feb       Impact factor: 1.896

3.  The polymorphisms of IL-6/STAT3 signaling pathway may contribute to cutaneous T-cell lymphomas susceptibility.

Authors:  Berenika Olszewska; Jolanta Gleń; Monika Zabłotna; Roman J Nowicki; Małgorzata Sokołowska-Wojdyło
Journal:  Arch Dermatol Res       Date:  2020-04-08       Impact factor: 3.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.